Klar2O has secured a €4.5 million investment led by FMC Beteiligungs KG, marking a major step in scaling our molecular filtration technology for global application. This investment enables us to expand production capacity, initiate international pilot studies, and accelerate the deployment of our patented Smart Surface Technology — a silica-based innovation designed to remove nanoplastics and PFAS directly at the molecular level.
What began as a laboratory vision has evolved into a deep-tech platform capable of addressing one of the most persistent environmental challenges of our time. Nanoplastics and PFAS are now detected in blood, organs, and even the placenta — a clear signal that purity in drinking water must move beyond conventional filtration. Klar2O’s approach combines biochemical engineering and material science to capture these invisible contaminants with measurable precision.
The investment is more than capital; it is a statement of confidence in the idea that clean water should not depend on chance, but on chemistry. It allows Klar2O to transition from pilot-scale validation to industrial manufacturing, strengthening partnerships with leading analytical laboratories and regulatory bodies worldwide.
At the center of this achievement stands a dedicated team — scientists, engineers, and operators who transform complex chemistry into functional systems. Their work bridges innovation with responsibility, proving that sustainability can be scientifically verified.
We extend our gratitude to our investors, partners, and supporters who believe in this mission. This is not an endpoint; it is the beginning of scaling purity as a global standard.
Pure water begins at the molecular level — and Klar2O is building that future.
Visit klar2o.com to explore the science behind measurable purity.